This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Corneal cross-linking for treatment of corneal ulcers

Corneal cross-linking for treatment of corneal ulcers
Reviewed by Bushra Thajudeen

1 February 2019 | Bushra Thajudeen | EYE - Cornea, EYE - General

This was an observational cohort study looking at the usefulness of photo activated chromophore for infectious keratitis-corneal collagen cross-linking (PACK-CXL) in reducing the time to heal in suppurative corneal ulcers. This study, conducted in a tertiary care centre in South India, had two arms; The prospective arm of 13 patients with suppurative corneal ulcers who underwent PACK – CXL and a retrospective cohort of 32 consecutive patients who had been admitted and treated at the same centre for a similar profile of ulcers in the previous one year. All patients aged between 18 and 75 years, with a corneal ulcer size of 2-6 mm (largest diameter) and a positive smear or culture for bacteria or fungus were included. Exclusion criteria were suspected viral keratitis, proven Acanthamoeba keratitis, ulcers with more than 50% corneal thinning on slit-lamp evaluation, patients with a history of previous PACK-CXL. All patients were treated with standard medical therapy who then underwent additional CXL (Dresden protocol) within 48 hours of admission. PACK-CXL was performed up to a maximum of four sessions, with an interval of 48 hours between therapy sessions. The study outcome parameters were either 1) healing (closure of epithelial defect) or 2) nonhealing (failed treatment) of ulcer. The mean number of days for the time to heal was 48.8 (SD, 36.7) days in the retrospective group and was 23.2 (SD, 14.3) days in the prospective group. A mean reduction from 48.8 to 23.2 days is clinically significant although not statistically significant. Four of the 32 patients (12.5%) in the retrospective cohort had treatment failure with one of the 11 (9.09%) in the cohort treated with PACK-CXL (p=0.97). The authors conclude that this pilot study suggests that PACK-CXL with more than one exposure may be a potential valuable addition to the management of patients with bacterial and fungal corneal ulcers.

PACK-CXL in reducing the time to heal in suppurative corneal ulcers: Observations of a pilot study from South India.
Basaiawmoit P, Selvin ST, Korah S.
CORNEA
2018;37(11):1376-80.
Share This
Bushra Thajudeen
CONTRIBUTOR
Bushra Thajudeen

Singleton Hospital, Swansea, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency